Fisher Asset Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 850529 PLANO, TX

Position in TNGX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$3,397,387

+$1,734,428 QoQ

Shares Held

162,399

-13.5% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fisher Asset Management, LLC holds $671,245,647 across 48 Biotechnology names. TNGX ranks #33 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	1,113,568	$69,820,713
2	CYTK	Cytokinetics Inc	768,264	$50,636,280
3	RCUS	Arcus Biosciences, Inc.	2,190,404	$47,312,726
4	DNLI	Denali Therapeutics Inc.	2,436,895	$46,788,384
5	VRDN	Viridian Therapeutics, Inc.\DE	1,768,295	$34,587,850
6	CLDX	Celldex Therapeutics, Inc.	1,013,648	$32,152,914
7	CGON	CG Oncology, Inc.	465,033	$31,473,433
8	IDYA	IDEAYA Biosciences, Inc.	882,699	$29,411,530

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,397,387	162,399	-13.5%	Shares	Defined	2026-05-05
2025-12-31	$1,662,959	187,693	-10.8%	Shares	Defined	2026-02-09
2025-09-30	$1,766,956	210,352	-6.1%	Shares	Defined	2025-11-12
2025-06-30	$1,147,274	224,077	0.0%	Shares	Defined	2025-08-13
2025-03-31	$306,985	224,077	+44.6%	Shares	Defined	2025-05-14
2024-12-31	$478,786	154,947	0.0%	Shares	Defined	2025-02-05
2024-09-30	$1,193,091	154,947	0.0%	Shares	Defined	2024-11-12
2024-06-30	$1,329,445	154,947	+53.9%	Shares	Defined	2024-08-14
2024-03-31	$799,486	100,691	0.0%	Shares	Defined	2024-05-09
2023-12-31	$996,840	100,691	—	Shares	Defined	2024-03-05
No filing history on record for this holder in this stock.